Jean-paul Kress
Independent Member
Biogen Inc
India
Biography
Dr. Jean-Paul Kress, M.D., has been appointed as Executive Vice President, President - International and Head of Global Therapeutic Operations of the Company., effective June 19, 2017. Dr. Kress was most recently senior vice president, head of North America at Sanofi Genzyme, where he oversaw the multiple sclerosis, oncology, and immunology business units in the U.S. and Canada. Prior to his 2015 arrival at Sanofi Genzyme, he spent four years as president and chief executive officer of Sanofi Pasteur MSD leading a variety of functions, including sales and marketing, market access, supply chain support, and medical affairs. Dr. Kress holds graduate and post-graduate degrees in biochemistry and molecular and cellular pharmacology from Ecole normale superieure, Paris, and an M.D. from Faculte Necker-Enfants Malades, Paris. His industry experience also includes leadership roles with Eli Lilly, Abbott Laboratories, and Gilead Sciences.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology
